Research Protocols / Metabolic
5-Amino-1MQ research protocols: NNMT inhibition, concentrations, and published findings
5-Amino-1MQ is a small-molecule NNMT inhibitor that reached the research market through adipocyte metabolism work. Here is what the published literature actually reports, how concentrations are expressed, and how to reconstitute a 50 mg vial.
5-Amino-1-methylquinolinium, almost always written 5-Amino-1MQ, is not a peptide. It is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), and it is stocked alongside peptide reference standards because the metabolic research programs that use it overlap heavily with those using GLP-1 analogues and mitochondrial peptides. That distinction matters for handling: solubility, storage, and stability behave like a small molecule, not like a lyophilized peptide.
Mechanism: what NNMT inhibition actually does
NNMT catalyses the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide and S-adenosylhomocysteine. Two consequences drive the research interest:
- Nicotinamide sequestration. Nicotinamide is a precursor in the NAD+ salvage pathway. Every molecule methylated by NNMT is a molecule unavailable for NAD+ regeneration. In tissues where NNMT is highly expressed, notably white adipose tissue and liver, elevated NNMT activity correlates with reduced NAD+ availability.
- SAM consumption. NNMT is a substantial methyl sink. High NNMT activity depletes the SAM pool, which shifts the SAM to SAH ratio and alters the cell's capacity for other methylation reactions, including histone methylation.
Knockdown studies in rodent models published from 2014 onward reported that reducing NNMT expression in adipose tissue protected against diet-induced obesity, with the proposed mechanism running through increased cellular NAD+ and elevated energy expenditure in adipocytes. 5-Amino-1MQ emerged as a cell-permeable small-molecule tool to reproduce that knockdown pharmacologically rather than genetically.
The research value of 5-Amino-1MQ is that it lets you interrogate the NNMT axis acutely and reversibly, in a system where genetic knockdown would take weeks and confound developmental effects.
Concentrations reported in the literature
Published work expresses 5-Amino-1MQ exposure in two very different units depending on model system. Conflating them is the most common protocol error we see referenced.
| Model system | Typical reported range | Unit convention |
|---|---|---|
| Cell-free NNMT enzyme assay | Low micromolar IC50, commonly cited near 1.1 uM | Molar concentration |
| Cultured adipocytes (in-vitro) | Roughly 10 to 100 uM in culture medium | Molar concentration |
| Rodent models (in-vivo) | Reported on a mg per kg body weight basis | Mass per body mass |
Molecular weight for the iodide salt commonly supplied is approximately 286 g/mol, so a 1 mM stock requires roughly 0.286 mg per mL. Confirm the salt form and molecular weight on your lot certificate before computing molarity, because free base and salt forms differ enough to matter at the low micromolar range.
Reconstitution and solubility
Our 50 mg vial is the standard research unit. 5-Amino-1MQ is water soluble, which distinguishes it from many small-molecule inhibitors that require DMSO. Practical notes:
- Bacteriostatic water is the default solvent for stock preparation. Sterile water works where the benzyl alcohol preservative would interfere with a downstream assay, but the resulting solution is single-use.
- Prepare a concentrated stock, then dilute. A 50 mg vial in 5 mL gives 10 mg/mL, a convenient parent stock that dilutes cleanly into working ranges.
- Aliquot before freezing. Small molecules tolerate freeze-thaw better than peptides do, but repeated cycles still introduce concentration drift through condensation on the vial wall. See our freeze-thaw stability guide.
- Protect from light. Quinolinium compounds are photosensitive. Amber tubes or foil-wrapped aliquots are standard practice.
Tolerability signals in the preclinical record
Published rodent work reports that 5-Amino-1MQ was well tolerated across the dosing windows studied, with no significant changes in food intake reported in several diet-induced-obesity models, which is mechanistically interesting because it points toward an energy-expenditure effect rather than an appetite effect. What the literature does not contain is a substantial human safety dataset. There are no completed large-scale clinical trials, no established human pharmacokinetics, and no regulatory approval in Canada or elsewhere. Any claim you encounter about outcomes in people is extrapolating from rodent data across a species barrier that NNMT biology does not obviously respect, since NNMT expression patterns differ meaningfully between mouse and human adipose tissue.
Related reading
NNMT sits directly upstream of NAD+ availability, so this compound is frequently studied alongside NAD+ itself. See our NAD+ research overview for the salvage-pathway side of the same axis, and the 5-Amino-1MQ reference page for CAS number, molecular weight, and PubMed entry points.
Sourcing and verification
Purity matters more than any protocol detail. A concentration curve computed from a vial that is 88% peptide and 12% truncated sequence is not reproducible, and the failure is invisible until you compare it against another lot. Every Lumera Labs lot ships with a lot-specific certificate of analysis reporting HPLC-UV purity, and those certificates are posted publicly at Lab Results before you order, not emailed afterward. Orders ship from within Canada in 24 to 48 hours, free over $200 CAD, so there is no customs exposure and no multi-week transit window for temperature-sensitive material.
FAQ
Is 5-Amino-1MQ a peptide?
No. It is a small-molecule quinolinium compound with a molecular weight near 286 g/mol, roughly one fifth the size of BPC-157. It is grouped with research peptides commercially because the metabolic research programs overlap, but it handles like a small molecule: water soluble, more freeze-thaw tolerant, and photosensitive.
What concentration is used in cell culture studies?
Published in-vitro adipocyte work generally sits in the 10 to 100 micromolar range in culture medium, against a cell-free enzyme IC50 commonly cited near 1.1 micromolar. Confirm molecular weight and salt form from your lot certificate before converting mass to molarity.
How do I reconstitute a 50 mg vial?
5 mL of bacteriostatic water gives a 10 mg/mL parent stock that dilutes cleanly into working ranges. The compound is water soluble and does not require DMSO. Aliquot into amber or foil-wrapped tubes and freeze, since quinolinium compounds are photosensitive.
What does the preclinical literature report about tolerability?
Rodent studies report the compound was well tolerated across the windows studied, with no significant change in food intake in several diet-induced-obesity models. There is no substantial human safety dataset, no established human pharmacokinetics, and no regulatory approval.
How does 5-Amino-1MQ relate to NAD+?
NNMT methylates nicotinamide, removing it from the NAD+ salvage pathway. Inhibiting NNMT preserves nicotinamide for NAD+ regeneration, which is why the compound is often studied alongside NAD+ precursors as two approaches to the same axis.
Continue reading